KALA - Kala Pharmaceuticals' (KALA) CEO Mark Iwicki on Q1 2019 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA)
Q1 2019 Earnings Conference Call
May 9, 2019 8:00 AM ET
Company Participants
Mary Reumuth – Chief Financial Officer
Mark Iwicki – Chairman, President and Chief Executive Officer
Todd Bazemore – Chief Operating Officer
Kim Brazzell – Chief Medical Officer
Hongming Chen – Chief Scientific Officer
Conference Call Participants
Shveta Vilas – Wedbush
Esther Rajavelu – Oppenheimer
Yi Chen – H.C. Wainwright
Presentation
Operator
Good morning, and welcome to Kala Pharmaceuticals First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks,